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Abstract 
 
Vascular cognitive impairment (VCI) post stroke is frequent, but may go undetected, which 
highlights the need to better screen cognitive functioning post stroke. We sought to examine the 
diagnostic accuracy of the Montreal Cognitive Assessment (MoCA), a cognitive screening 
measure recommended for use with stroke populations. We assessed cognitive status in 161 
individuals who were at least 3 months post stroke with a comprehensive battery of 
neuropsychological measures. We compared diagnostic accuracy using a single cut point 
compared to two cut points and determined that sensitivity and specificity were optimal when 
two cut points were applied. This resulted in three groups, where 27% of participants scored £ 23 
and were classified as high likelihood of cognitive impairment, and 25% of participants scored ³ 
28 and were classified as low likelihood of cognitive impairment. The remaining 47% of 
participants scored from 24 to 27 and were classified as indeterminate likelihood of cognitive 
impairment. The addition of a processing speed measure improved classification for this group 
by correctly classifying 71% of the individuals in this category. We provide a three-category 
diagnostic approach to better identify individuals as certain and uncertain likelihood of cognitive 
impairment. The addition of a processing speed measure provides a practical and efficient 
method to increase confidence in the determined outcome, while also expanding the utility of the 
MoCA
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1 
Accuracy of the Montreal Cognitive Assessment (MoCA) in Detecting Cognitive Impairment 
following Stroke 
 
Cognitive impairment post stroke can result in significant physical and psychological 
consequences for the individual. These effects, in turn, place a significant financial burden on the 
health care system (Rockwood et al., 2000). In Canada, stroke is the number one cause of 
disability in adults, as 30% of men and 40% of women with cognitive impairment post stroke 
become dependent on institutions for full-time care (Rockwood et al., 2000; Rockwood, Ebly, & 
Hachinski, 1997). Furthermore, as many as 77% of individuals with stroke with cognitive 
impairment have been reported to go undetected by cognitive screening measures (Chan et al., 
2014).  In a 5-year follow-up of individuals with vascular cognitive impairment (VCI), Wentzel 
and colleagues (2001) found that 46% of individuals without dementia at baseline developed 
dementia over the study period. This is a similar rate of progression to dementia for individuals 
with mild cognitive impairment (MCI). These findings highlight the importance of accurate 
detection of individuals who are at high risk of progressing to dementia due to vascular disease. 
Early detection can allow for early intervention, which may lead to better functional long-term 
outcomes for those who are at risk.   
Despite its enormous social and economic impact, cognitive impairment post stroke is 
still not well understood, with no standardized clinical screening criteria for detecting early 
impairment and identifying at-risk individuals. Furthermore, not all individuals with stroke 
develop cognitive impairment, and many experience only transient or mild symptoms (Gorelick 
et al., 2011; Wentzel et al., 2001). Thus, cognitive decline post stroke is not inevitable; variance 
in cognitive changes may be due to risk factors associated with the onset of stroke and their 
cerebrovascular mechanisms, as well as the severity and location of the cerebrovascular damage.  
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Screening Cognition Post Stroke 
 Best-practice guidelines recommend the use of cognitive screening tests with individuals 
with stroke (Eskes et al., 2015). Cognitive screening tests are readily available and used with 
stroke populations in a variety of settings, including primary health care and post-operative 
settings. These screening measures are typically employed to differentiate cognitive changes that 
are considered normal from those that represent impairment (Blackburn, Bafadhel, Randall & 
Harkness, 2012). The Montreal Cognitive Assessment (MoCA) was developed by Nasreddine 
and colleagues (2005) to help point-of-care physicians detect subtle cognitive changes early in 
the course of neurodegenerative disease, namely MCI. It is important to note that the MoCA was 
originally designed to be sensitive to memory changes that differentiate MCI from normal aging 
(Nasserdine et al., 2005), and memory impairment may not necessarily be characteristic of stroke 
populations. Nonetheless, it is now a widely used cognitive screening measure, and the test has 
been recommended by the National Institute of Neurological Disorders and Stroke-Canadian 
Stroke Network (NINDS-CSN) for use with stroke populations (Hachinski et al., 2006). The 
convenience of rapid test administration and support across several disease populations including 
cardiovascular conditions (Hawkins et al., 2014; McLennan, Mathias, Brennan, & Stewart, 
2011), Parkinson’s disease (Zadikoff et al., 2008; Dalrymple-Alford et al., 2010) and traumatic 
brain injury (Wong et al., 2013) has increased the use of the MoCA for a variety of clinical 
populations. 
The MoCA can be administered in under 10 minutes and yields a single total score out of 
30. According to the authors, scores below 26 reflect possible cognitive impairment. Although 
the test is designed to yield a global measure of cognitive impairment, the items are generally 
grouped together based on cognitive domains, and individual subscale scores can be calculated 
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for each cognitive domain. The test examines eight domains: visuospatial skills, executive 
functions, object perception, memory, attention, language, abstraction and orientation. The 
inclusion of items that place demand on executive functions has been viewed as a strength of the 
MoCA over other screening measures, arguably making it more sensitive to the type of cognitive 
impairment that is most characteristic of individuals with vascular disease (Cees De Groot et al., 
2000; Garrett et al., 2004; Koski, 2013; Price, Jefferson, Merino, Heilman, & Libon, 2005). 
Although post stroke cognitive impairment profiles can be quite variable depending on stroke 
location and severity, several studies have found that individuals with cerebrovascular conditions 
are more likely to lose points on items of executive functions, fluency and recall subtests than on 
any other subtests of the MoCA (Cumming, Bernhardt, & Linden, 2011; Martinić-Popović, 
Lovrenčić-Huzjan, & Demarin, 2009; Toglia, Fitzgerald, O'Dell, Mastrogiovanni & Lin, 2011). 
Similarly, Pendlebury et al. (2012) found that nondemented individuals with stroke performed 
worse than those without stroke on MoCA items of executive functions, fluency, and attention. 
These differences on item performance are seen even among those individuals who score within 
normal limits on other screening measures, such as the Mini-Mental Status Examination 
(MMSE).  
These findings suggest that the MoCA may better detect impairment that is specific to 
vascular conditions compared to other screening measures. Specifically, the MoCA has been 
shown to have better sensitivity than the MMSE in a variety of disease populations, including 
VCI and MCI (Dong et al., 2010; Godefroy et al., 2011;Hachinski et al., 2006; Nasredine et al., 
2005; Pendlebury, Cuthbertson, Welch, Mehta, & Rothwell, 2010). The MoCA is thought to be 
more cognitively demanding than the MMSE and therefore less likely to yield ceiling effects and 
more likely to capture subtle cognitive changes (Godefroy et al., 2011;Hachinski et al., 2006; 
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Nasredine et al., 2005; Pendlebury, et al., 2010). 
Processing Speed 
Despite the clear support for the use of the MoCA for cerebrovascular conditions, it does 
not include a measure of processing speed, which is often affected in stroke populations (Garrett 
et al., 2004; Patel, Coshall, Rudd & Wolfe, 2003; Rockwood et al., 2000). Speed of information 
processing can easily be assessed by tests that can be administered in under two minutes. For 
example, the Symbol-Digit Modalities Test (SDMT; Smith, 1982) was first designed as a 
screening measure to identify individuals with neurological impairment. It assesses functions 
such as visual scanning, psychomotor speed, attention and learning. A comprehensive review of 
the SDMT (Strauss, Sherman, & Spreen, 2006) indicates that the SDMT is one of the most 
sensitive tests to brain insult in neuropsychology with a large number of studies documenting its 
utility to detect cognitive impairment, changes in functioning, and disease progression in a 
variety of disease including the standardized evaluation of traumatic brain injury (Ponsford & 
Kinsella, 1992), multiple sclerosis (Beatty et al., 1995; Solari et al., 2002), Huntington’s disease 
(Huntington, 1996) and concussion (Erlanger, et al., 2003). In particular, one study found that 
processing speed, as measured by the SDMT, was one of the domains that best discriminated 
between cognitively impaired and intact individuals among those with vascular symptoms 
(Sachdev et al., 2004).  The importance of processing speed has also been noted in the MoCA 
literature. For example, Chan et al. (2014) found that more than 50% of acute stroke individuals 
were impaired on measures of processing speed, despite scoring in the normal range on the 
MoCA. Similarly, Pendlebury et al., (2012) attributed the MoCA’s low sensitivity in detecting 
nonamnestic single-domain cognitive impairment to a lack of measuring slowed processing 
speed.  
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MoCA Cut Point Accuracy 
  Several studies have investigated the diagnostic accuracy of the MoCA using the 
traditional cut point of 26, with scores ³ 26 considered in the normal range and scores £ 25 
indicative of cognitive impairment. However, this dichotomous approach may lead to a reliance 
on using the screening test as a diagnostic tool in diagnosing cognitive impairment (Webb et al., 
2014) instead of as a screening measure. In some research studies, the MoCA has been used to 
reflect severity of cognitive impairment rather than likelihood by specifying a set range of scores 
to reflect mild or severe cognitive impairment (Webb et al., 2014). Using a single cut point to 
determine dichotomous outcomes may not accurately capture the range of functioning in a 
clinical setting. False negatives, in particular (i.e., identifying cognitively impaired individuals as 
intact), may result in a failure to follow up with further investigations and a failure to treat or 
intervene where necessary (Wong et al., 2015). An alternative method of screening, using 
receiver operator characteristics (ROC) curves, is to create multiple-group classifications to 
compare functioning across a range of diagnostic certainty (Attwood, Tian, & Xiong, 2014; 
Nakas, Alonzo, & Yiannoutsos, 2010). Indeed, Swartz and colleagues (2016) suggested a three-
group classification approach using ROC curves to determine optimal sensitivity and specificity 
cut points for the MoCA for individuals with cerebrovascular symptoms to create a more useful 
classification screening system. This approach identifies individuals as low likelihood (above the 
top cut point), high likelihood (below the bottom cut point), and indeterminate likelihood 
(between the two cut points) of cognitive impairment. This three-group approach is useful for 
categorizing individuals who have a high probability of being intact or impaired, but it also 
leaves a group of individuals between the two cut points as unknown or indeterminate likelihood 
of having cognitive impairment. In the latter case, a more detailed assessment would be needed 
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to determine the presence or absence of cognitive impairment. 
  In the present study, we sought to confirm the three-group classification approach using 
ROC curve analysis to identify post-acute stroke individuals that are at low, high or 
indeterminate likelihood of cognitive impairment as identified by a gold-standard, detailed 
neuropsychological assessment. To improve classification and reduce the number of people in 
the indeterminate category, we conducted two additional analyses. First, we examined whether 
performance on specific subdomains of the MoCA provides more information than using the 
single global score to categorize individuals in the indeterminate category. Second, we examined 
the inclusion of processing speed using the SDMT, in addition to the MoCA total score, to 
examine whether this provides additional predictive utility to the MoCA. 
Method 
Participants 
Participants were obtained from the Ontario Neurodegenerative Disease Research 
Initiative (ONDRI), which is an ongoing longitudinal, multidisciplinary research study 
investigating common profiles among five neurodegenerative conditions (Farhan et al., 2017). 
Only the vascular cognitive impairment (VCI) cohort was used in the present study. All 
participants were tested across various assessment platforms including genomics, neuroimaging, 
ocular function, and gait and balance, as well as language and neuropsychological testing. 
Demographic, clinical, and neuropsychological data obtained from the first, baseline assessment 
were used for this study. All participants were administered the MoCA as part of the screening 
procedure, and the neuropsychological battery was administered within 8 weeks of initial 
screening with the MoCA.  
All participants provided informed consent and met extensive eligibility criteria for the 
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larger ONDRI study (Farhan et al., 2017). All participants in the VCI cohort also met the 
following inclusion criteria: (a) proficient in speaking and understanding English, with self-
ratings of 7 or more (corresponding to “good”) for both speaking and understanding English on 
the Language Experience and Proficiency Questionnaire (Marian, Blumenfeld, & Kaushanskaya, 
2007), (b) eight or more years of formal education, (c) post-acute (³ 3 months) ischemic stroke 
or silent stroke that was documented on MRI or CT, (d) mild-moderate stroke severity defined 
by scores of 0-3 on the modified Rankin Scale (Bonita & Beaglehole, 1988; Rankin, 1957), and 
(e) a MoCA score of at least 18. Exclusion criteria included a history of dementia prior to the 
stroke, large cortical strokes, severe cognitive impairment, aphasia, inability to write, or severe 
functional disability limiting ability to perform the assessment.  
Participant Characteristics  
Participant characteristics are provided in Table 1. There was a total of 161 participants 
with approximately a 1:2 ratio of women to men. Participants were in their late 60s on average 
and had some university education (M = 14.5 years).  
Assessments 
The MoCA is a 49-item cognitive screening test with a possible score range of 0 to 30. It 
assesses eight cognitive domains, as listed in Table 2 and included in the appendix. As per the 
published scoring protocol (Nasreddine et al., 2005), an education correction of one additional 
point is applied to the total score for participants with £ 12 years of education. 
The SDMT is a 110-item substitution task that is used to assess processing speed and 
incidental learning. The test consists of symbols that are matched to numbers from 1 to 9 
according to a key printed at the top of the test form. First the participants were presented with a 
series of symbols, and asked to write the numbers with which the symbols are associated as 
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quickly as possible in 90 seconds. The score is the total number of items filled in correctly during 
the time limit (max = 110). The second part of the test consisted of a line of 15 symbols in which 
all 9 original symbols were included at least once. Participants were asked to fill in the number 
associated with that symbol, from memory, without the assistance of the key. The score is the 
number of items recalled correctly during the time limit (max = 15). In cases where a symbol 
was presented more than once, and the participant correctly identified the number on one 
occasion and incorrectly identified it on another, the participant was given credit for the correct 
identification. The purpose of this was to assess the incidental learning component of the task. 
Therefore, two scores were obtained for the SDMT: speeded processing and recall (learning).  
  The neuropsychological assessment consisted of a standardized battery administered to 
all participants. The tests were categorized into six cognitive domains based on a principle 
component analysis (Troyer et al., 2017), as shown in Table 3. Test scores were normalized 
based on age, education, and sex using published norms from their respective test manuals and 
converted to standardized scores. Participants were deemed cognitively impaired on the 
neuropsychological battery if they obtained a standardized score that was lower than 1.5 standard 
deviation (SD) below the mean on at least two tests within one or more domains.  
Statistical Analyses 
All statistical analyses were conducted in SPSS Version 22.0. Descriptive characteristics 
were examined to calculate the effects of age, education and sex on MoCA scores. To examine 
performance on the neuropsychological battery, we identified participants scoring in the normal 
range on the MoCA using the traditional cut point of MoCA ³ 26 and investigated their 
performance on the neuropsychological tests and cognitive domains. Our primary analysis 
consisted of calculating measures of diagnostic accuracy of the traditional cut point score of ³ 
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26, including sensitivity, specificity, positive and negative likelihood ratios, and positive and 
negative predictive values. We then used ROC curves to maximize sensitivity and specificity to 
determine an optimal single cut point, and to determine a three-group classification with two cut 
points: one with high sensitivity and a second with high specificity. Participants scoring below 
the high sensitivity cut point were classified as high likelihood for cognitive impairment, and 
participants scoring above the high specificity cut point were classified as low likelihood. 
Participants scoring between the two cut points were classified as indeterminate or unknown 
likelihood of cognitive impairment. Measures of diagnostic accuracy were calculated for all cut 
point analyses.  
  To improve classification for the indeterminate group, a second analysis was conducted 
using discriminant function analysis to build a predictive model for group membership to 
correctly classify participants as impaired or not impaired as determined by their performance on 
the neuropsychological battery. We examined two sets of variables to create two separate 
discriminant functions. First, we examined the predictive value of distinct MoCA subdomain 
items, rather than the total MoCA score, to investigate if scores on specific cognitive domains of 
the MoCA better characterize participants in each group. Secondly, we examined the utility of 
SDMT, paired with the total MoCA score, to examine whether the additional metric of 
performance on processing speed and incidental learning allows for more accurate discrimination 
of participants’ cognitive status than using their MoCA total score alone. Participants from the 
high and low likelihood of cognitive impairment groups were used first to develop the 
discriminant functions, and then the models were tested on the indeterminate group. The cross-
validated classification method was used to indicate the final number of cases correctly identified 
by each function. This method employs the leave-one-out technique in which one case is 
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systematically held out and the discriminant analysis is performed on the remaining sample. 
Then, the excluded case is classified into one of the groups based on the discriminant function 
and the procedure is repeated on each case of the sample until all cases are classified. This results 
in a more conservative estimate of the number of cases correctly identified by the function 
(Brown & Wicker, 2000). This method was used to indicate the number of cases correctly 
identified based on the predictor variables in the model.  
Results 
Neuropsychological Data 
Of the 161 participants, 100 (62%) met the criterion for cognitive impairment (³ 1.5 SD 
on ³ two subtests in at least one domain) on the neuropsychological battery. Fifty-six 
participants (35%) were impaired on two or more cognitive domains, and 21 (13%) were 
impaired on three or more domains. As seen in Table 3, among those who were impaired on at 
least one domain, processing speed and memory were the most frequently impaired domains. 
The visual spatial domain was the third most common impairment, whereas fewer than 10% of 
the participants were impaired on language, attention and object perception.  
The Brief Visuospatial Memory Test (BVMT) loaded on to two cognitive domains, 
namely memory and visual-spatial, in the original PCA (Troyer et al., 2018). Ten individuals 
were impaired on only the BVMT variables. In order to determine whether that impaired 
performance should be classified in the memory or visual-spatial domain, these ten cases were 
individually reviewed by two clinical neuropsychologists. Although no additional test variables 
met the criterion of 1.5 SD below the mean or lower, we considered performance around 1 SD 
below the mean to indicate a relative weakness in that domain. Seven of the 10 participants 
showed this level of performance on at least one additional memory or visual-spatial variable. 
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The remaining 3 participants performed well within the normal range on all other variables. 
Because the BVMT variables load slightly more highly on the memory domain than the visual-
spatial domain in our earlier work (Troyer et al., 2017), their impaired level of BVMT 
performance was interpreted as reflecting memory impairment. 
MoCA Performance 
The mean MoCA score was 25.3, with 47% of participants scoring below the traditional 
cut point of 26 and 53% participants scoring at or above the cut point. In a multivariate 
regression model, age and education were significant predictors of MoCA score (R2 = .095, p < 
.001), where older participants (b = -0.102, p < .001) and those with fewer years of education (b 
=.186, p = .022) had lower MoCA scores. Sex (b = .028, p = .955) did not significantly predict 
MoCA scores. Table 4 presents a frequency count of the number of participants who were 
cognitively impaired or intact based on the neuropsychological battery as a function of MoCA 
score.  
Next, we examined neuropsychological performance of the MoCA pass (³26) and MoCA 
fail (£25) groups based on the recommended cut point of 26. Of the 86 individuals in the MoCA 
pass group, 36 (42%) were impaired on at least one of the neuropsychological domains. 
Regarding the areas of impairment, 26 (30%) participants were impaired on speed, 17 (20%) 
were impaired on memory, 6 (7%) were impaired on visual perception, 1 (1%) was impaired on 
language, 1 (1%) was impaired on attention, and 8 (9%) were impaired on object perception. Of 
these 86, 15 (17%) were impaired on two or more domains, and 7 (8%) were impaired on three 
or more domains on the neuropsychological battery.  
Of the 75 individuals in the MoCA fail group, 64 (85%) were impaired on at least one of 
the neuropsychological domains. Thirty-nine (52%) were impaired on speed, 47 (63%) were 
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impaired on memory, 13 (17%) were impaired on visual perception, 13 (17%) were impaired on 
language, 5 (7%) were impaired on object perception and no individual was impaired on the 
attention domain. Of these individuals, 41 (55%) were impaired on two or more domains, and 14 
(19%) were impaired on three or more domains.  
Measures of Diagnostic Accuracy Analysis 
Using the traditional single cut point of MoCA ³ 26, sensitivity was 64% and specificity 
was 82%. Our ROC analysis indicated that the optimal single cut point, which maximized 
sensitivity and specificity, was for MoCA ³ 27. The optimal two cut points were MoCA £ 27 (to 
maximize sensitivity) and MoCA ³ 24 (to maximize specificity). All results are summarized in 
Table 5. Using two cut points, 27% of participants scored £ 23 and were classified as high 
likelihood for cognitive impairment, and 25% of participants scored ³ 28 and were classified as 
low likelihood for cognitive impairment. The remaining 47% of participants scored in the range 
of 24 – 27 and were classified as indeterminate likelihood for cognitive impairment.  
Discriminant Function Analysis 
Discriminant function analysis (DFA) was used to examine the usefulness of MoCA 
subdomain scores in predicting whether individual domains of the MoCA were better at 
discriminating individuals in the indeterminate MoCA group as impaired or not impaired on the 
neuropsychological battery. Eight MoCA variables were created by grouping scorable items into 
their respective cognitive domains determined by consensus of two neuropsychologists, as 
shown in Table 2. The discriminant function was significant, L = .49, c2(8) = 55.26, p < .001, 
accounting for 51% of between-group variability. Analysis of the structure matrix correlation 
coefficients which reveal the strength of each variable with the function indicated that items of 
delayed recall (r = .725), attention (r = .562), visual reconstruction (r = .447), language fluency 
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(r = .411), immediate memory recall (r = .354), and abstraction (r = .341) were significant group 
predictors, whereas object naming and orientation did not reach significance, r < .30 (Brown & 
Wicker, 2000). The cross-validated classification showed that overall, 67 of 84 cases in the high 
or low groups, or 80%, were correctly identified based on the predictors in the model, as shown 
in Table 6. Next, in order to test the predictive utility of the model, we conducted a discriminant 
function analysis on the indeterminate MoCA group alone. The discriminant function for the 
indeterminate group was not significant, L = .820, c2 (8) = 13.49, p = .096, and accounted for 
18% of between-group variability. 
Next, we examined the predictability of the MoCA total score paired with the SDMT. 
The SDMT was removed from the neuropsychological battery before conducting analyses. This 
changed cognitive status for two participants who were originally impaired on the SDMT and 
only one other measure in the speed domain on the neuropsychological battery. Once the SDMT 
was removed, these two participants no longer met criteria for cognitive impairment on the 
neuropsychological battery.  
We entered two subscores from the SDMT in the DFA, a speed subscore and a learning 
subscore. The discriminant function was significant, L = .512, c2 (3) = 54.55, p < .001, 
accounting for 49% of between-group variability when tested on the high and low likelihood of 
cognitive impairment groups. Analysis of the structure matrix scores revealed that the MoCA 
total score and SDMT speed score were significant group predictors, rs = .979 and .685, 
respectively, whereas the SDMT learning score did not reach significance, r = -.096. The cross-
validated classification showed that overall, 70 of 85 cases, or 82%, were correctly identified, as 
shown in Table 7. Next, we tested this model for the indeterminate group alone. The discriminant 
function for the indeterminate group was also significant, L = .842, c2 (3) = 12.48, p < .01, 
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accounting for 16% of between-group variability. Analysis of the structure matrix revealed that 
the MoCA total score, SDMT speed score, and the SDMT learning score were all significant 
predictors of group membership for the indeterminate group, rs = .833, .593, and .543, 
respectively. The cross-validated classification showed that overall, 54 of 76 cases, or 71%, were 
correctly identified for this group, as shown in Table 8. 
Discussion 
Recommendations for screening cognitive impairment post stroke pose a challenge as the 
standard evaluation must accommodate disease heterogeneity but also be specific and feasible in 
a clinical setting. Although there is no single neuropsychological impairment profile for 
cognitive impairment post stroke, executive dysfunction and slowed processing speed are two 
prominent features of both VCI and vascular dementia. Therefore, these two domains should be 
assessed when screening for cognitive impairment post stroke. The MoCA was developed to 
detect mild cognitive impairment in neurodegenerative disease, with the original study based on 
a cohort of participants recruited from memory clinics (Nasreddine et al., 2005). It is a more 
sensitive test than the MMSE in detecting MCI, and it holds promise for detecting VCI because, 
unlike the MMSE, it includes items assessing executive functions.  
The strategy for cognitive screening should be informed by the purpose of the clinical or 
research question. If the purpose of the initial screening is to pick-up all potential cases to allow 
for further assessment, then using a measure that is highly sensitive (low rate of false negatives) 
may be preferable. This ensures that those at high likelihood of impairment will receive 
appropriate treatment. It could be argued that for initial screening, sensitivity is often preferred 
compared with specificity. However, in a clinical setting false positives may pose a costly 
outcome when busy clinics and expensive treatments are used for individuals who do not need 
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them. As such our findings in this study directly address these issues by helping to correctly 
identify those who need the resources and those who do not.  
 We propose that using a three-group approach to identifying individuals at risk of 
cognitive impairment closely represents the thought process in a clinical setting. Identifying 
individuals who are at low, intermediate, and high likelihood of cognitive impairment is an 
effective method of triaging, where clinicians can be highly certain in their decision to determine 
which individuals should be sent for neuropsychological referrals. We found that using two cut 
points rather than a single cut point for the MoCA allowed us to increase the test’s sensitivity 
and specificity to higher than 90%. Individuals who scored > 27 and < 24 made up our low and 
high likelihood of cognitive impairment groups, respectively. This means that the cognitive 
status determined by performance on the neuropsychological battery was correctly identified by 
the MoCA for more than 90% of individuals within these two groups. While this approach 
improves the diagnostic accuracy of the MoCA compared to the single cut point approach, where 
both sensitivity and specificity were below 80%, almost half of our participants scored in the 
middle range of the MoCA, between the two cut points. Thus, we were uncertain of the 
likelihood of cognitive impairment for almost half of the participants in our sample, based on 
their MoCA score alone. In studies favoring the single cut point, there is great variability in the 
range of reported cut points varying from scores £ 19 to £ 26 (Cumming et al., 2011; Dong et al., 
2010; Dong et al., 2012; Godefroy et al., 2011; Lees et al., 2014; Pendlebury et al., 2010; 
Salvadori et al., 2013; Wong et al., 2009; Wu, Wang, Ren, & Xu, 2013). This variability can in 
part be explained by choosing to favor either optimal sensitivity or specificity, or choosing an 
arbitrary “optimal” point to balance both sensitivity and specificity, compromising the overall 
accuracy of the test. Additionally, it is important to acknowledge that cognition is inherently a 
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complex phenomenon which is difficult to measure with screening measures, and therefore 
variability in performance should be expected. Several noncognitive factors such as mood, 
fatigue, age, education, and motivation have been reported to contribute to fluctuating scores on 
various tests of cognition (Visser-Keizer, Jong, Deelman, Berg, & Gerritsen, 2002). With the 
three-group approach we directly address this heterogeneity and better divide individuals into 
certain and uncertain likelihood of cognitive impairment to help clinicians determine appropriate 
candidates for further testing.    
Using this approach, three groups emerged: those who are at high likelihood of cognitive 
impairment, those at low likelihood of cognitive impairment, and those with indeterminate 
likelihood. With this approach, only individuals who fall in the indeterminate group require 
further assessment. The high likelihood group was the most homogenous group, where most of 
the participants were impaired on the neuropsychological battery and correctly identified by the 
MoCA. The low risk group had more variability with some participants who had MoCA scores 
of  ³ 28 but were identified as impaired on the neuropsychological battery. Lastly, the 
intermediate group emerged as the largest group and consisted of approximately half of our 
sample, where almost two-thirds of them had impairment on the neuropsychological battery. 
To address the unknown likelihood of cognitive impairment of the indeterminate group, 
we found that pairing an additional neuropsychological test, the SDMT, with the total MoCA 
score improved classification for this group, such that the majority of cases in this uncertain 
range were correctly identified. We found that both the processing speed and learning subscores 
of the SDMT provided discriminant utility for the indeterminate group, whereas only the 
processing speed subscore was useful in categorizing individuals in the certain (high and low 
likelihood) groups. The added discriminant utility of processing speed with the MoCA is 
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consistent with past research that suggests slowed processing speed is characteristic of cognitive 
impairment post stroke. Our findings suggest that where resources are limited and to avoid 
unnecessary referrals, employing an additional quick 90-second processing speed measure can 
increase confidence in the determined outcome. This approach is both practical and efficient, as 
many processing speed measures are readily available (such as the SDMT used by us) and can be 
completed in under 2 minutes in any clinical setting, making them an ideal addition to a 
screening test. While the incidental learning subscore was also significant in discriminating 
cognitive impairment, it was only significant for the indeterminate group. Although some studies 
have reported impaired visual and verbal learning in vascular dementia (Sachdev et al., 2004), 
incidental learning is not commonly assessed. Studies that have used the SDMT with VCI, and 
report impairment on the test, do not clarify if both trials, the incidental learning and processing 
speed were administered (Pendlebury et al., 2012; Sachdev et al., 2004). This warrants further 
investigation to determine whether subtle changes in incidental learning may be a domain of 
early cognitive impairment in post stroke individuals.  Nonetheless, the discriminant utility of 
processing speed suggests that this domain should be assessed post stroke.  
Adding processing speed also expands the domains assessed by the MoCA to detect 
impairments in populations other than the one it was originally designed for (i.e., MCI). This 
crucial cognitive domain is often impacted in several disorders (e.g., multiple sclerosis, 
Parkinson’s disease, Huntington’s disease; Zadikoff et al., 2008; Dalrymple-Alford et al., 2010), 
and has been reported as a critique of the MoCA’s reduced sensitivity for those with vascular 
disease (Chan et al., 2014; Pendlebury et al., 2012) The addition of the SDMT directly addresses 
these concerns, while also appropriately extending the use of the MoCA so it is efficient in 
detecting impairment that is characteristic of the population that it is being used for.  
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 We also found that examining individual subdomains of the MoCA did not significantly 
improve its ability to discriminate cognitive impairment for the indeterminate group. This further 
reflects the heterogeneity of vascular disease, and as such no distinct pattern of individual 
subdomains of the MoCA was better at identifying individuals in the indeterminate category. 
This also further speaks to the heterogeneity inherent in screening cognition. Although there is a 
group of individuals who can be classified with certainty by using maximum sensitivity and 
specificity cut points, there remains a sub-group whose cognitive abilities remain undetermined 
by quick screens, even with the addition of a processing speed measure that improves 
classification of the indeterminate group by more than two-thirds. No screening tool can be 
perfect, so there will always be a subgroup that warrants further assessment. Given the cost in 
terms of time, money, and medical resources of conducting a comprehensive neuropsychological 
battery, the goal is to reduce this subgroup as much as possible. 
This study represents a pragmatic approach, with a clean sample of post-acute stroke 
individuals and a large sample size; nevertheless, there are some limitations to our design. First, 
the study required volunteers and thus this self-selection process may have resulted in 
participants that are not best representative of the general post-acute stroke population. 
Participants may have been higher functioning than seen in the general clinic by virtue of the 
study requirements: they had to have sufficient motor, language, hearing and visual functioning 
to complete neuropsychological testing. Additionally, we used a definition of cognitive 
impairment that best represents mild-moderate risk of ³ 1.5 SD on two or more tests in a single 
domain (often used in mild cognitive impairment literature) rather than severe impairment, thus 
resulting in a higher prevalence rate of cognitive impairment in our sample than other studies 
that used a more conservative definition (i.e. ³ 2 SD). However, only a little over half of our 
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sample was cognitively impaired using our definition, suggesting that we had good variability of 
cognitive performance in our sample where our impaired and intact groups were close to equal. 
This is important because the prevalence rate of disease (i.e., cognitive impairment in our case) 
directly affects the predictive value of a test. Additionally, our criteria requiring impairment on 
two or more tests within a single domain, rather than one test, was designed to identify 
individuals with single domain cognitive impairment that are unlikely to be found by chance 
alone, and who would more likely require clinical assessment to determine their prognosis of 
cognitive functioning. Finally, the cognitive domains used in our definition of cognitive 
impairment were based on a principle component analysis determined on this sample. This 
restricts the generalizability of the results to other diseases, as the same tests might not load 
together to form the same cognitive domains in different disease cohorts.  
Future research should examine the utility of the SDMT as a stand-alone screening 
measure for post stroke individuals. As mentioned earlier, the test was originally designed as a 
screening tool (Smith, 1982), and it is highly sensitive to brain insult. Although we were 
interested in using the test for its measure of processing speed, the processing speed trial could 
also be assessing attention, visual scanning, and memory, thus, these functions may contribute to 
task performance. It could also be possible that these domains, as well as incidental learning may 
be sufficient in discriminating early cognitive impairment in vascular disease, as suggested by 
the significance of incidental learning in our results. In addition, it would be useful to investigate 
the discriminate utility of a range of processing speed measures to better tease apart the role of 
processing speed and other cognitive domains affected in vascular disease. 
In conclusion, we provide a clinically useful approach to stratify post-acute stroke 
individuals into three groups forming homogenous groups of low and high likelihood of 
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cognitive impairment as well as a group in the intermediate range. These groups form useful 
clinical categories to separate those who may need to be prioritized with immediate attention in 
the high likelihood group, from those who should be sent for further assessment in the 
indeterminate group, while also identifying those who do not require immediate management 
and are unlikely to have cognitive impairment in the low likelihood group. We further provide a 
practical and efficient method to increase certainty of cognitive impairment for the indeterminate 
group while also expanding the domains assessed by the MoCA by pairing it with an additional 
processing speed measure. Our results show that with the inclusion of the SDMT with the MoCA 
total score we could correctly discriminate cognitive status for majority of the individuals in the 
indeterminate category. This approach helps to expand the MoCA for use with stroke 
populations, while also improving the breadth of the test without compromising the qualities of a 
screening tool. This provides an efficient method to increase the diagnostic accuracy of the 
MoCA allowing clinicians to better detect individuals in need of further assessment.  
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Table 1 
Participant Characteristics 
All Participants (n = 161) 
 M (SD) n 
Age, years 68.7 (7.4)  
Education, years 14.5 (2.9)  
Sex   
  Male  110 (68%) 
  Female  51 (32%) 
MoCA score 25.3 (3.1)  
MoCA impairment (< 26)  75 (47%) 
MoCA indeterminate group (scores 24 – 27)    76 (47%) 
NP impairment  100 (62%) 
Note. NP impairment = ³ 1.5 SD below the mean on ³ 2 subtests within a cognitive domain 
 
  
 
 
31 
Table 2 
 MoCA Domain Items 
MoCA Domains Individual MoCA Items and Points Per Item Total points 
Per Domain 
Attention  Forward digit span (1) 
Backward digit span (1) 
Tap for each letter A (1) 
Serial 7 subtraction (3) 
Repeat first sentence (1) 
Repeat second sentence (1) 
10 
Delayed recall Recall with no cue (5) 
Recall with category cue (5) 
Recall with multiple choice cue (5) 
15 
Visual construction Trails (1) 
Cube copy (1) 
Clock drawing (3) 
5 
Abstraction  Similarity (2) 2 
Language Fluency   Raw number of words generated for fluency (25) 25 
Immediate recall  First trial of recall (5) 
Second trial of recall (5) 
10 
Object Naming  Naming 3 animals (3) 3 
Orientation  Date (1) 
Month (1) 
6 
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Year (1) 
Day (1) 
Place (1) 
City (1) 
 
 
  
 
 
33 
Table 3  
Neuropsychological Data 
Neuropsychological 
Domain 
Tests included Number (and 
percent) of 
participants 
impaireda 
Speed Symbol-Digit Modalities 
Trail Making Test, Part A  
Trail Making Test, Part B  
Stroop Colour Naming 
Stroop Word Reading 
Stroop Inhibition 
Stroop Switching  
Verbal Fluency Letters 
Verbal Fluency Categories 
65 (40%) 
Memory  Rey Auditory Verbal Learning Test Immediate recall 
Rey Auditory Verbal Learning Test delayed recall  
Rey Auditory Verbal Learning Test recognition hits  
Brief Visuospatial Memory Test immediate recall  
Brief Visuospatial Memory Test delayed recall 
Brief Visuospatial Memory Test recognition discrimination 
64 (40%) 
Visual Spatial  Wechsler Adult Intelligence Scale Matrix Reasoning, 
Judgment of Line Orientation  
19 (12%) 
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Brief Visuospatial Memory Test immediate recall 
Brief Visuospatial Memory Test delayed recall 
Language Wechsler Adult Intelligence Scale Vocabulary 
Boston Naming Test  
Verb Naming 
Semantic Probe 
14 (9%) 
Attention Digit-Span Backwards  
Digit-Span Forward  
Digit-Span total 
1 (1%) 
Object Perceptionb Incomplete Letters 13 (8%) 
a Impairment = ³ 1.5 SD below the mean on ³ 2 subtests within a cognitive domain. 
b This domain was considered impaired if individuals were impaired on the single test within the 
domain (incomplete letters)  
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Table 4 
Number of Participants Impaired vs. Not Impaired on the Neuropsychology Battery as a 
Function of MoCA Score  
MoCA 
Score 
Impaired 
(n) 
Not impaired 
(n) 
18 2 0 
19 8 0 
20 7 0 
21 3 1 
22 7 0 
23 12 4 
24 13 2 
25 12 4 
26 15 7 
27 12 11 
28 5 10 
29 3 14 
30 1 8 
Total 100 61 
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Table 5 
Diagnostic Accuracy Analysis and Optimal Cut Points 
 
Diagnostic 
Characteristics 
Traditional Cut Point 
³ 26 
Single Optimal Cut 
Point ³ 27 
Two Optimal Cut 
Points  
Sensitivity: £ 27 
Specificity: ³ 24 
Sensitivity 64% 79% 91% 
Specificity 82% 70% 91% 
PPV 85% 81% 89% 
NPV 58% 67% 78% 
+LR 3.55 2.68 4.76 
-LR 0.44 0.30 0.17 
Participants below cut 
point 
75 (47%) 97 (60%) <24 = 44 (27%) 
>27 = 41 (25%) 
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Table 6 
Predicted Group Membership Based on MoCA Domains for High and Low Groups 
  Classification by DF   
 NP impaired No Yes  
Count No 32 5 37 
 Yes 12 35 47 
% No 86.5 13.5 100.0 
 Yes 25.5 74.5 100.0 
Note. 80% of cross-validated grouped cases correctly classified; NP impaired = cognitive status 
based on neuropsychological battery 
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Table 7 
Predicted Group Membership using MoCA Total Score and SDMT for High and Low Groups 
Cross-Validated Classification Results High and Low Groups 
  Classification by DF  
 NP impaired No Yes  
Count No 32 5 37 
 Yes 10 38 48 
% No 86.5 13.5 100.0 
 Yes 20.8 79.2 100.0 
Note. 82% of cross-validated grouped cases correctly classified; NP impaired = cognitive status 
based on neuropsychological battery 
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Table 8  
Predicted Group Membership using MoCA Total Score and SDMT for Indeterminate Group  
Cross Validated Classification Results Indeterminate Group  
  Classification by DF  
 NP impaired No Yes  
Count No 11 15 26 
 Yes 7 43 50 
% No 42.3 57.7 100.0 
 Yes 14.0 86.0 100.0 
Note. 71% of cross-validated grouped cases correctly classified; NP impaired = cognitive status 
based on neuropsychological battery 
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